Filing Details

Accession Number:
0001298900-12-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-18 16:58:08
Reporting Period:
2012-05-31
Filing Date:
2012-06-18
Accepted Time:
2012-06-18 16:58:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298900 Gary Titus 950 Tower Lane, Suite 900
Foster City CA 94404
Senior Vp Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-31 261 $3.84 37,095 No 4 P Direct
Common Stock Acquisiton 2012-06-14 15,029 $0.95 52,124 No 4 M Direct
Common Stock Disposition 2012-06-14 15,029 $7.05 37,095 No 4 S Direct
Common Stock Acquisiton 2012-06-15 36,954 $0.95 74,049 No 4 M Direct
Common Stock Disposition 2012-06-15 36,954 $6.99 37,095 No 4 S Direct
Common Stock Acquisiton 2012-06-15 29,624 $0.95 66,719 No 4 M Direct
Common Stock Disposition 2012-06-15 29,624 $6.99 37,095 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-06-14 15,029 $0.00 15,029 $0.95
Common Stock Incentive Stock Option (right to buy) Disposition 2012-06-15 36,954 $0.00 36,954 $0.95
Common Stock Incentive Stock Option (right to buy) Disposition 2012-06-15 29,624 $0.00 29,624 $0.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
134,971 2018-12-16 No 4 M Direct
98,017 2018-12-16 No 4 M Direct
68,393 2018-12-16 No 4 M Direct
Footnotes
  1. Purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2012.
  2. Granted under the Issuer's 2005 Equity Incentive Plan.
  3. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
  4. Provided Reporting Person remains employed by the Issuer, the Option will vest based on the achievement of certain performance targets on or prior to December 31, 2010, with 25,000 shares respectively vesting upon attainment of each of three specified goals. If these targets are not achieved on or before December 31, 2010, the Option will not vest and will terminate at that time.